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IntroductIon
Wegener’s Granulomatosis (WG) is a multisystem disorder 
characterized  by  granulomatous  necrotizing  vasculitis. 
Classic Wegener’s granulomatosis is a triad of necrotizing 
angiitis of the upper and lower respiratory tract and focal 
glomerulonephritis  of  the  kidney.1 The  classic  respiratory 
feature is multiple pulmonary nodules on chest radiograph.2 
In many cases extensive medical evaluation and laboratory 
test have proven non-diagnostic. In 1966, Carrington and 
Liebow  introduced  the  concept  of  “limited  Wegener’s” 
granulomatosis to identify otherwise classic vasculitis lacking 
renal involvement.3 Limited Wegener’s granulomatosis has a 
better prognosis than classic disease but it may be extremely 
challenging to recognize and diagnose.3, 4
We report an unusual case of limited Wegener’s granulomatosis 
presenting with focal endobronchial WG with lobar collapse 
requiring stenting.
CaSE REpoRt  A 19 year old female student presented to 
Otorhinolaryngology in June 1997 with a 3-week history of 
nasal obstruction, anosmia, headache, post-nasal drip and 
cough, unresponsive to recurrent antibiotic courses. X-Ray of 
paranasal sinuses revealed both maxillary sinus opacity. She 
was admitted in January 1998 for bilateral antral washouts 
and nasal endoscopy. Postoperatively, she developed fever, 
malaise, anorexia and unexplained weight loss. CT scan of 
paranasal  sinuses  revealed  pansinusitis.  She  had  bilateral 
functional endoscopic sinus surgery without much benefit. 
A CT Scan of brain excluded intracranial abscess. Revision 
endoscopic sinus surgery, performed 9 days later, revealed 
pus with necrotic material in the maxillary sinuses. Despite 
repeated sinus drainage procedures and intravenous broad-
spectrum antibiotics during her hospitalisation, she continued 
to be febrile with weight loss. She had persistently elevated 
C  –  reactive  protein  [130  –  393  mg/l].  Her  Westergren 
erythrocyte sedimentation rate was 110mm/hour. All cultures 
were negative. No granuloma or fungus was observed on 
biopsies. Initial autoimmune and vasculitic tests demonstrated 
no elevation in autoantibodies. She developed a normocytic 
anaemia, transient polyarthralgia and destructive inflammation 
of her nasal bridge.
Despite  the  initial  absence  of  granuloma  on  histology  or 
Anti Neutrophil Cytoplasmic Antibody (ANCA) in serum, 
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was made. The patient was commenced on high dose oral 
steroids  and  co-trimoxazole.  Steroid  therapy  resulted  in 
prompt  response  and  rapid  clinical  improvement,  evident 
within 24 hours.
Indirect  serum  immunofluoresence  in  early  February 
1998 showed an atypical positive pattern for cANCA and 
Antiproteinase 3 level 6.2U/L [Normal <2]. Cyclophosphamide 
was added to her management regime. Rapid symptomatic 
improvement followed and she was discharged home.
In June 1998 she presented acutely unwell with shortness 
of breath and fever. A chest radiograph revealed complete 
collapse of the left lower lobe (fig.1). Bronchoscopy confirmed 
Fig 1.  Chest X-ray pre-stent.
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complete  occlusion  of  the  left  main  bronchus. Treatment 
was  commenced  with  intravenous  methylprednisolone, 
cyclophosphamide  and  antibiotics.  Repeat  bronchoscopy 
and biopsy of firm tissue at the stenosed left main bronchus 
showed  superficial  fragments  of  oedematous  and  reactive 
mucosa with extensive squamous metaplasia. There was no 
dysplasia, malignancy, granulation, vasculitis or fungus. Rigid 
bronchoscopy  with  laser  ablation  of  the  stenotic  segment 
followed by dilatation was performed. Rapid improvement 
ensued.
Her health deteriorated within three weeks, with restenosis 
of  the  left  main  bronchus.  Repeat  bronchoscopy  and 
laser  ablation  of  stenotic  segment  followed  by  dilatation 
gave immediate relief. Restenosis occurred and the cycle 
continued. In a 2-month period, a total of 9 dilatations were 
carried out, several with laser resection. Each gave transient 
symptomatic relief.
The patient proceeded to stenting in October 1998. Rigid 
bronchoscopy provided accurate measurement of the extent of 
the stenotic segment of left main bronchus. An endobronchial 
stent was deployed after laser ablation and balloon dilatation 
(fig. 2). 
Fig 2.  Chest X-ray post stent
She improved dramatically following stenting. Follow up at 
the respiratory outpatient clinic enabled slow tapering of her 
steroid therapy to zero by July 2000. All bloods were normal 
and azathioprine therapy was discontinued in October 2000. 
She underwent nasal reconstructive surgery in 2001. She was 
able to complete her studies and was married early in 2003. 
Her only complaints during this 5-year period were occasional 
upper respiratory tract infections, which responded well to 
short courses of oral antibiotics.
A  deterioration  in  FEV1  late  in  2003  raised  suspicion  of 
restenosis (FEV1 3.4L May 2002 - FEV1 1.75L November 
2003).  Bronchoscopy  in  November  2003  demonstrated  a 
well epithelialised, stented left main bronchus with mobile, 
occluding but not actively inflamed, tissue at the distal end 
of stent. In the coming weeks she was monitored closely. At 
surgical review in February 2004 she was 8 weeks pregnant 
and subjectively well. Intervention was postponed.
A further acute presentation with a left lower lobe pneumonia 
occurred in April 2004. Subsequent bronchoscopy revealed 
a circumferential stenosis of greater than 50% at the origin 
of the left main bronchus. Histology confirmed recurrence 
of acutely inflamed granulation tissue and laser ablation was 
undertaken in May 2004.
She had a baby girl by caesarean section in September 2004. 
In 2005 laser debulking of the endobronchial lesion has been 
performed twice. A repeat biopsy in January 2005 revealed 
further  stent  hyperplasia  with  granulation  tissue.  Both 
treatments have provided symptomatic relief.
dIscussIon
In  this  patient  the  upper  airway  disease  due  to 
Wegener’s  Granulomatosis  responded  to  corticosteroids, 
cyclophosphamide and co-trimoxazole. Endobronchial WG 
is an uncommon manifestation of the disease. Koyama et al 
(2003) reported the incidence of endobronchial involvement 
to be as low as 16%.5 Hirsch et al (1992) further stressed 
the rarity of endobronchial WG. They described a patient 
in whom the only manifestation of WG is severe proximal 
bronchial stenosis, which developed despite management with 
oral steroid and cyclophosphamide. That case responded well 
to IV cyclophosphamide and oral co-trimoxazole whereas our 
case required further intervention.6 A further case report by 
Breton et al (1986), illustrated the difficulty in diagnosing 
WG from such a presentation and emphasise the need for 
tissue biopsy.7 These highlight the importance of awareness 
of this infrequent but potentially life-threatening feature of 
the condition.
Subsequent to presentation with left main bronchus occlusion, 
our patient underwent repeated dilatation and laser ablation 
therapy. Each of these afforded her only temporary relief 
of airway obstruction. Several authors suggest that balloon 
dilatation is safe, efficacious and cost-effective.8, 9 It is easily 
performed and has few complications. Eagleton et al found 
repeated endoscopic dilatation effective for 18 months in 
a  patient  with  endobronchial  WG.10  Until  now,  no  long-
term follow up has been published. When combined with 
laser therapy, endoscopic dilatation may be acceptable as a 
first line measure to restructure the occluded airway but to 
further enlarge the airway and maintain patency, stenting is 
required.
Endobronchial stenting is not without complication. Problems 
include  displacement  of  the  stent  and  obstruction  with 
secretions  or  granulation  tissue  (as  in  our  patient).  Less 
commonly the stent may perforate the airway wall, sometimes 
into  the  accompanying  blood  vessel.11  Most  studies  of 
endobronchial stenting demonstrate that they are an effective 
treatment modality for airway stenosis. The long term efficacy 
of endobronchial stents is superior to laser ablation, debulking 
or dilatation therapy though the long term patency of stents 
is uncertain.12-14
Stents have been effective in achieving immediate resolution 
of  respiratory  symptoms  from  various  tracheobronchial 
obstructions.15 In the majority of cases, however, the success 
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of  such  a  management  option  cannot  be  judged  on  such 
short term outcomes. Currently, the ideal course of action 
is unclear, as none are free from complications, nor able to 
consistently provide life-long patency.15
This  patient’s  endobronchial  stenosis  was  successfully 
managed  with  endobronchial  stenting  which  maintained 
airway patency for 5 years. No other reports were found with 
such encouraging longterm outcomes.
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